Clinical Trial Update: Abatacept Versus Adalimumab Head-to-Head [Phase 3]

View source ↗

Summary

A Phase 3 head-to-head trial compared abatacept with adalimumab in rheumatoid arthritis; results were posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)
• ORENCIA (ABATACEPT)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2014-01-03